Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |